One Allentown Parkway
United States - Map
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products for medical applications primarily in the United States and Canada. The companys fluid delivery products comprise luer syringe check valves and one-way valves; tubing clamps; and specialized intravenous sets for use in anesthesia and oncology applications. Its cardiovascular products include MPS2 Myocardial Protection System that delivers essential fluids and medications to the heart during open-heart surgery; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The companys ophthalmic products comprise contact lens disinfection cases; and a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. It also manufactures instrumentation and associated disposables used to measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, the company produces inflation systems and valves used in marine and aviation safety products; and one-way and two-way pressure relief valves for use on electronics cases, munitions cases, pressure vessels, transportation container cases, escape slides, and other medical and non-medical applications. Atrion Corporation sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. The company was founded in 1944 and is headquartered in Allen, Texas.
|ATRION Corp.’s ISS Governance QuickScore as of Aug 1, 2014 is 8. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 10; Compensation: 4.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Emile A. Battat ,
Exec. Chairman, Member of Exec. Committee and Chairman of Halkey-Roberts Corp.
|Mr. David A. Battat ,
Chief Exec. Officer, Pres and Pres of Halkey-Roberts Corp. - Sub
|Mr. Jeffery Strickland ,
Chief Financial Officer, Principal Accounting Officer, VP, Sec. and Treasurer
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|